Feng Shi

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Song Chen, Zhiqiang Wu, Feng Shi et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver

Shu‐Feng Zhou, Wenhua Li, Feng Shi et al. · Drug Design Development and Therapy · 2015 · 57 citations · Full text

Medicine, Molecular Medicine, Pharmacology +16

Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes

Feng Shi, Ming‐Shiang Wu, Shan-Shan Lian et al. · Radiology · 2019 · 50 citations · Full text

Medicine, Oncology, Surgery +14

Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma

Lujun Shen, Wang Li, Siyang Wang et al. · Radiology · 2016 · 37 citations

Medicine, Biostatistics, Oncology +17

Microwave ablation <i>versus</i> radiofrequency ablation for the treatment of pulmonary tumors

Feng Shi, Guangxiao Li, Zejian Zhou et al. · Oncotarget · 2017 · 31 citations · Full text

Medicine, Oncology, Surgery +8